SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Clinical trials for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) trials appear
Sign up with your email to follow new studies for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks ilaris safety in rare fever patients
Disease control Recruiting nowThis study watches children and adults with certain rare fever diseases (like CAPS, FMF, TRAPS, HIDS/MKD, and sJIA) who are already taking or starting Ilaris. Researchers will track side effects and how well the drug controls fevers and flares. No new treatment is given — it just…
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Gentler transplant approach offers hope for young patients with rare blood diseases
Disease control Recruiting nowThis study tests a milder chemotherapy and transplant method for children and young adults up to age 55 with serious non-cancer blood disorders like immune deficiencies, anemias, and metabolic diseases. The goal is to see if this gentler approach can safely replace the patient's …
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated May 01, 2026 15:58 UTC